(19)
(11) EP 2 744 484 A1

(12)

(43) Date of publication:
25.06.2014 Bulletin 2014/26

(21) Application number: 12750726.7

(22) Date of filing: 08.08.2012
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/44(2006.01)
(86) International application number:
PCT/EP2012/065513
(87) International publication number:
WO 2013/023970 (21.02.2013 Gazette 2013/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.08.2011 EP 11177863
17.08.2011 US 201161524432 P

(71) Applicant: Ratiopharm GmbH
89079 Ulm (DE)

(72) Inventors:
  • STEFAN, Ralph
    88370 Ebenweiler (DE)
  • JANSSEN, Christian
    30159 Hannover (DE)
  • STUMM, Daniela
    10367 Berlin (DE)

(74) Representative: Teipel, Stephan et al
Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2
80538 München
80538 München (DE)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING 4-[4[[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYLAMINO]PHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE